Application of Dexketamine Combined with Sufentanil in Postoperative Analgesia of Elderly Patients with Gastrointestinal Tumors

Application of S-ketamine combined with sufentanil in postoperative analgesia of gastrointestinal tumor surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050432

Enrollment

Unknown

Registered

2021-08-27

Start date

2021-08-28

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal tumor

Interventions

LSF:Dex-ketamine + sufentanil group

F:Sufentanil

SF:Dex-ketamine + sufentanil group

Eligibility

Sex/Gender

All

Age

60 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Inpatients who underwent elective laparoscopic radical gastrointestinal tumor resection in gastrointestinal surgery, aged 18-70 years; 2. ASA I-III class.

Exclusion criteria

Exclusion criteria: 1. Long-term use of analgesics; 2. Anyone who has an adverse reaction to D-ketamine or ketamine; 3. Hypertension patients; 4. Patients with increased intracranial pressure and glaucoma; 5. Patients with mental illness; 6. History of vertigo; 7. And other cases where dexketamine is not applicable.

Design outcomes

Primary

Measure	Time frame
Consumption of analgesic drugs;	—

Secondary

Measure	Time frame
Pain Numerical Score;PCIA compression times;Ramsay Calm Score;Depression Self-Rating Scale Score;Adverse effect;	—

Countries

China

Contacts

Public ContactDu Yu, Wang Ji

Nanchong Central Hospital

542861618@qq.com+86 182 2739 0636

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026